# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024465
Filing Date
2022-11-10
Accepted
2022-11-10 16:12:35
Documents
79
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | amlx-20220930.htm iXBRL | 10-Q | 4324322
2 | EX-31.1 | amlx-ex31_1.htm | EX-31.1 | 21516
3 | EX-31.2 | amlx-ex31_2.htm | EX-31.2 | 21508
4 | EX-31.3 | amlx-ex31_3.htm | EX-31.3 | 21508
5 | EX-32.1 | amlx-ex32_1.htm | EX-32.1 | 11979
6 | EX-32.2 | amlx-ex32_2.htm | EX-32.2 | 11977
7 | EX-32.3 | amlx-ex32_3.htm | EX-32.3 | 12016
| Complete submission text file | 0000950170-22-024465.txt |  | 11734588

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | amlx-20220930_lab.xml | EX-101.LAB | 471157
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | amlx-20220930_def.xml | EX-101.DEF | 214914
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | amlx-20220930_pre.xml | EX-101.PRE | 366994
11 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | amlx-20220930.xsd | EX-101.SCH | 53220
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | amlx-20220930_cal.xml | EX-101.CAL | 53179
73 | EXTRACTED XBRL INSTANCE DOCUMENT | amlx-20220930_htm.xml | XML | 1955806

Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

EIN.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41199 | Film No.: 221377296
SIC: 2834 Pharmaceutical Preparations